White House Shuts Down Petition for Psych Drug Investigation

Shortly after the Newtown, Connecticut school shooting, a petition was created on Whitehouse.gov asking the government to launch an investigation into the relationship between school shootings and psychiatric drugs.

Within a few days, the administration, or someone from Whitehouse.gov, allegedly shut down the entire petition early (it was supposed to remain up for 30 days and it was shut down at only 7 days!), meanwhile allowing another to receive continuous attention and even a video from President Obama showing his support for it.

Our friend and a new blogger with The Bitter Pill, Daniel Guild, created this video. Please watch and share.

A new petition was then created, and you can sign it here: http://www.thepetitionsite.com/967/364/876/demand-federal-investigation-into-psychiatric-drugs-school-shootings/

Dan Jenski – ADDicted

Kickstarter is a website for artists to use to raise money and complete awesome projects. The best thing to come to the informed consent movement since Thomas Szasz could just be the new, upcoming film by Dan Jenski, “ADDicted” which basically gives Ritalin, Adderall, Concerta and the like a great big gigantic middle finger. Dan is a friend of mine and I see huge potential in his work. I’m thinking Oscar. The short film version of ADDicted has made it into film festivals all across the country and now Dan and his co-producer Aaron Bickes need to raise enough money to be able to create the feature length film.

With fewer and fewer days left in this important campaign, you can make a difference today for future generations of children, high school, college, and graduate students BEFORE their moms, teachers, dads and doctors get a chance to diagnose them with some kind of problem leading to the use of risky and damaging, potentially fatal stimulants. This project needs donations. Please help us spread the word.

Check it out at http://www.kickstarter.com/projects/libproductions/addicted-feature-film?ref=live

Also read what award-winning writer Kelly O’Meara has to say about it here:

http://www.cchrint.org/2013/02/26/kick-starting-a-worthy-film-addicted/

Zoloft Fails to Outperform Placebo: Class Action

In the studies submitted to the FDA for approving Zoloft (a drug that has killed numerous families, babies, mothers, children), the drug maker covered up the fact that Zoloft failed to outperform placebo, according to a new consumer fraud lawsuit filed by the firms Baum, Hedlund Aristei & Goldman and Pendley Baudin & Coffin.

Many of you already know about the Irving Kirsch reports which examined the combined total of all antidepressant studies including those which were never submitted to the FDA. What you may not be aware of, is the level of manipulation required to achieve the appearance of the effect that Zoloft was as good as or better than placebo in the faked studies that were submitted. If you know of all the horrible effects (aka “side effects”) of antidepressants, you may be wondering, “Where is the supposed benefit if it is all negative, deadly stuff that we are dealing with?”

The answer is, there are no benefits compared with a placebo. According to Attorney Michael Baum of Baum, Hedlund, Aristei & Goldman, the alleged benefits were “achieved” in studies by “unblinding” which means that study researchers know who is on the drug versus who is on the placebo. When the defective unblinded subjects were removed from the study, analyses showed that Zoloft failed to outperform placebo.

This is a travesty and something that one would hope could be caught by the FDA before this drug was ever approved.

The class action is for patients who were prescribed Zoloft for depression.

For more information, see the press release here: http://www.baumhedlundlaw.com/consumer-class-actions/zoloft-placebo-efficacy-class-action.php.

In Memory of Thomas Szasz

Image

Dr. Thomas Szasz has passed away at the age of 92 (Read More Here). We hope you will spend some time reading about his life and work. If you have something you would like to post as a memory or tribute, we suggest adding comments here on our tribute page, or on our Facebook page, or commenting on The Cato Institute’s Facebook Page.